@article{8b7ec48870794a159e38e3939750dd6c,
title = "Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR",
abstract = "Pharmacologic reversal of serious or intolerable side effects (SISEs) from vasodilator stress is an important safety and comfort measure for patients experiencing such effects. While typically performed using intravenous aminophylline, recurrent shortages of this agent have led to a greater need to limit its use and consider alternative agents. This information statement provides background and recommendations addressing indications for vasodilator reversal, timing of a reversal agent, incidence of observed SISE with vasodilator stress, clinical and logistical considerations for aminophylline-based reversal, and alternative non-aminophylline based reversal protocols.",
keywords = "MPI, MRI, PET, SPECT, vasodilators",
author = "Aiden Abidov and Vasken Dilsizian and Rami Doukky and Duvall, {W. Lane} and Christopher Dyke and Elliott, {Michael D.} and Hage, {Fadi G.} and Henzlova, {Milena J.} and Johnson, {Nils P.} and Schwartz, {Ronald G.} and Thomas, {Gregory S.} and Einstein, {Andrew J.}",
note = "Funding Information: Aiden Abidov, MD, PhD (Writing Committee Chair): Research Grant from NIH, GE Healthcare. Vasken Dilsizian, MD: Research Grant from Siemens, GE Healthcare. Rami Doukky, MD, MSc: Research Grant from Astellas. W. Lane Duvall, MD (Advisory Board): Jubilant DraxImage, GE Healthcare. Christopher Dyke, MD: none. Michael D. Elliot, MD: none. Fadi Hage, MD: Research Grant from Astellas, GE Healthcare. Milena J. Henzlova, MD, PhD: none. Nils P. Johnson, MD: institution has Licensing/Consulting Agreement with Boston Scientific for the Start-Minimum FFR Algorithm. Frequently invited by academia/industry to speak at educational meetings/conferences on coronary physiology or cardiac PET and receive travel expenses and sometimes an honorarium, which I donate to my institution. Ronald G. Schwartz, MD, MS (Speakers Bureau): Astellas. Gregory S. Thomas, MD: Research Grant to institution, Amgen and Novartis (CHF Trials). Speakers Bureau, Astellas. Andrew J. Einstein, MD, PhD (Writing Committee Co-chair): Research Grants to institution from NIH, Canon Medical Systems. Consultant, GE Healthcare. Drs. Abidov, Dilsizian, Doukky, Duvall, Hage, Henzlova, Johnson, Schwartz, Thomas, and Einstein served as ASNC representatives. Drs. Dyke and Elliot served as SCMR representatives. Publisher Copyright: {\textcopyright} 2018, The Author(s).",
year = "2019",
month = jun,
day = "15",
doi = "10.1007/s12350-018-01548-0",
language = "English (US)",
volume = "26",
pages = "1007--1014",
journal = "Journal of Nuclear Cardiology",
issn = "1071-3581",
publisher = "Springer New York",
number = "3",
}